Scientists have uncovered a previously overlooked mechanism that may help melanoma cells become effectively "immortal."
Cancer cells face a major problem before they can become deadly: They have to figure out how to stop aging.
Scientists have uncovered one of melanoma's key tricks for solving that problem. Researchers at the University of Pittsburgh School of Medicine report that the skin cancer uses a previously overlooked genetic partnership to keep its cells effectively immortal, allowing tumors to continue dividing long after normal cells would shut down.
The findings, published in Science, help explain why melanoma often develops unusually long telomeres, the protective DNA caps at the ends of chromosomes that normally wear down over time. The study also points to a possible new weakness in cancer cells that future treatments could target.
"We did something that was, in essence, obvious based on previous basic research and connected back to something that is happening in patients," said Jonathan Alder, Ph.D., assistant professor in the Division of Pulmonary, Allergy and Critical Care Medicine at Pitt's School of Medicine.
Every time a healthy cell divides, its telomeres become slightly shorter. Scientists often compare telomeres to the plastic tips on shoelaces because they help protect chromosomes from fraying or breaking apart.
Eventually, telomeres shrink to a critical length, triggering a process called replicative senescence. At that point, the cell can no longer divide. This natural limit acts as one of the body's important defenses against cancer.
Tumors must bypass that barrier to survive.
Many cancers accomplish this by reactivating telomerase, an enzyme that rebuilds telomeres and extends a cell's lifespan. In melanoma, mutations in the TERT gene, which produces telomerase, are especially common. About 75% of melanoma tumors carry these mutations.
But there was a puzzle researchers could not explain.
Even though TERT mutations increase telomerase activity, they did not fully account for the exceptionally long telomeres seen in melanoma tumors. When scientists recreated those mutations in laboratory cells, the telomeres still did not match what was observed in patients.
That suggested melanoma had another mechanism helping it preserve its chromosomes.
The missing partner hiding in plain sight
The breakthrough came when Pattra Chun-on, M.D., an internist and Ph.D. student in Alder's lab, focused on another gene called ACD, which produces a telomere-binding protein known as TPP1.
TPP1 is part of the "shelterin" complex, a group of proteins that protects telomeres and helps control access to them. One of TPP1's jobs is recruiting telomerase to chromosome ends.
While studying melanoma mutation databases, the researchers discovered recurring mutations in the promoter region of the ACD gene. Promoters are stretches of DNA that control how strongly a gene is turned on or off.
The mutations resembled the same type of promoter alterations already known to activate TERT. Both created new docking sites for ETS transcription factors, proteins that boost gene activity.

In effect, melanoma cells had evolved a two-part strategy. One mutation increased telomerase production through TERT, while the other improved the cell's ability to bring telomerase directly to telomeres through TPP1.
Together, the effects were far stronger than either mutation alone.
When the researchers introduced both mutated genes into cells, telomeres lengthened dramatically, closely matching the unusually long telomeres seen in melanoma tumors.
"Biochemists more than a decade before us showed that TPP1 increases the activity of telomerase in a test tube, but we never knew that this actually happened clinically," he said.
A discovery driven by persistence
Alder credited much of the breakthrough to Chun-on's determination.
"The fun part of this story is when Pattra joined my lab," Alder said. "She contacted me and told me that she was interested in studying cancer. I told her that I study short telomeres and not long telomeres. This went on until I realized that Pattra would never take 'no' for an answer."
Chun-on, who is also part of a Ph.D. program in the Department of Environmental and Occupational Health at Pitt's School of Public Health, ultimately helped identify the missing factor scientists had been searching for.
Lead author Pattra Chun-on later expanded on the findings in her 2023 Ph.D. dissertation at the University of Pittsburgh, which examined how melanoma cells use mutations in the TPP1 gene to maintain telomeres and bypass cellular aging. Her dissertation explored in greater detail how TPP1 mutations may cooperate with telomerase-related TERT mutations to help drive melanoma immortality.
Why melanoma may depend so heavily on telomeres
Melanoma develops from melanocytes, the pigment-producing cells in skin. These cells are routinely exposed to ultraviolet radiation from sunlight, which causes DNA damage over time.
Researchers believe melanocytes may face particularly intense pressure to maintain chromosome stability as mutations accumulate, making telomere control especially important in melanoma development.
"There's some special link between melanoma and telomere maintenance," said Alder. "For a melanocyte to transform into cancer, one of the biggest hurdles is to immortalize itself. Once it can do that, it's well on its way to cancer."
The study found that mutations in the TPP1 promoter appear in about 5% of cutaneous melanoma cases and frequently occur alongside TERT mutations instead of replacing them. That pattern suggests the mutations cooperate to help cancer cells overcome the normal limits on cell division.
A potential new target for cancer therapy
The discovery could eventually influence cancer treatment strategies.
Most healthy adult cells keep telomerase activity switched off, while cancer cells often depend on it for survival. By identifying a second component that helps melanoma sustain telomeres, researchers may have uncovered another potential therapeutic target.
Reference: "TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma" by Pattra Chun-on, Angela M. Hinchie, Holly C. Beale, Agustin A . Gil Silva, Elizabeth Rush, Cindy Sander, Carla J. Connelly, Brittani K.N. Seynnaeve, John M. Kirkwood, Olena M. Vaske, Carol W. Greider and Jonathan K. Alder, 10 November 2022, Science.
DOI: 10.1126/science.abq0607
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
An Ancient Virus May Hold the Secret to What Makes the Human Brain Different
Could a virus that infected chimpanzees millions of years ago help explain how the human brain became different? Researchers at Lund University have discovered that ancient viral DNA embedded in the chimpanzee genome silences [...]
Could a Nasal Spray Stop Alzheimer’s Before Memory Loss Begins?
Protecting memory from Alzheimer’s may one day involve a nasal spray, with encouraging results in animals and evidence that its particles also protect human neurons grown in the lab. Alzheimer’s disease damages the connections [...]
A sceptical guide to AI agents in drug discovery
In conversation with Dr Eric Ma, Senior Principal Data Scientist at Moderna, Dr Raminderpal Singh examines what AI agents are actually good for, where the lock-in hides and why expertise has become more valuable [...]
Study identifies new targets for antiviral drugs against coronaviruses
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including [...]
“Nearly Everybody Had Given Up” – Scientists Finally Solve a 60-Year Chemistry Mystery
After more than six decades of failed attempts, chemists have achieved a breakthrough involving a class of molecules long considered too unstable to isolate. Chemists have succeeded in isolating a group of molecules that [...]
Depression Symptoms Improved in Just 48 Hours After a Single Psychedelic Dose
A single dose of psilocybin produced rapid antidepressant effects in a small Swedish clinical trial, with improvements lasting for weeks. A single dose of psilocybin, the psychedelic compound found in magic mushrooms, produced rapid [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Human Bodies Are Producing Two Billion Tons of CO2 a Year
A new study reveals that the amount of carbon dioxide produced by human metabolism has increased dramatically over three decades. The carbon dioxide produced by human bodies as they convert food into energy increased [...]
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]















